Avenue Therapeutics, Inc

(NASDAQ:ATXI)

Latest On Avenue Therapeutics, Inc (ATXI):

Date/Time Type Description Signal Details
2023-05-12 20:47 ESTNewsAvenue Therapeutics GAAP EPS of -$1.37 misses by $1.24N/A
2023-04-18 20:42 ESTNewsAvenue Therapeutics makes progress in securing approval for Tramadol trialN/A
2023-03-31 01:25 ESTNewsAvenue Therapeutics GAAP EPS of -$1.63N/A
2023-03-02 13:24 ESTNewsAvenue stock surges ~15% on cash/stock licensing deal for neuromuscular disorder drug AJ201N/A
2022-11-15 15:34 ESTNewsAvenue Therapeutics GAAP EPS of -$0.45N/A
2022-10-07 13:11 ESTNewsAvenue Therapeutics shares slide on pricing $12M securities offeringN/A
2022-09-23 06:23 ESTNewsAvenue Therapeutics up 4% on 1-for-15 reverse stock splitN/A
2022-03-10 12:30 ESTNewsAbeona adds new CFO from Avenue TherapeuticsN/A
2022-03-01 21:28 ESTNewsAvenue Therapeutics trebles in value on rising volumeN/A
2022-02-16 14:20 ESTNewsAvenue Therapeutics gets FDA panel's rejection on IV pain drugN/A
2022-02-11 16:53 ESTNewsAvenue Therapeutics IV pain therapy to go under FDA review amid safety concernsN/A
2021-12-13 15:40 ESTNewsAvenue Therapeutics under pressure after pricing $2M stock offeringN/A
2021-11-30 00:18 ESTNewsFDA AdCom to review Avenue Therapeutics IV tramadol application on February 15, 2022N/A
2021-11-11 01:36 ESTNewsWarning: ATXI is at high risk of performing badlyN/A
2021-11-11 01:36 ESTNewsAvenue Therapeutics slumps after pricing public offering at $1.34N/A
2021-07-20 19:57 ESTNewsAvenue Therapeutics shares fall after FDA declines to approve IV tramadol pain medicineN/A
2021-07-20 19:57 ESTNewsEnochian Biosciences, RAPT Therapeutics leads healthcare gainers; Avenue Therapeutics, Inhibikase Therapeutics among major losersN/A
2021-04-13 10:01 ESTNewsAvenue Therapeutics shares slide after IV tramadol NDA updateN/A
2021-04-12 16:22 ESTNewsBABA, MARA, NUAN and CVAC among notable premarket gainersN/A
2021-04-09 18:29 ESTNewsFortress Biotech up 3% ahead of PDUFA for IV tramadolN/A
2021-01-02 15:10 ESTFinancialsCompany financials have been released.Neutral
2020-12-17 13:50 ESTNewsAvenue Therapeutics issues regulatory update for IV tramadolN/A
2020-12-13 03:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 15:11 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 07:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 17:09 ESTFinancialsCompany financials have been released.Neutral
2020-10-13 12:11 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.5 to $9.Neutral
2020-10-13 02:47 ESTNewsAvenue Therapeutics plunges on FDA response letterN/A
2020-09-26 04:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-21 16:46 ESTInsider TradeJoseph Walter Vazzano has directly disposed of 3,840 shares and currently holds 57,412 shares.Sell
2020-08-17 08:11 ESTFinancialsCompany financials have been released.Neutral
2020-08-16 08:10 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 13:22 ESTNewsAvenue Therapeutics EPS misses by $0.01N/A
2020-07-31 00:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 12:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:19 ESTFinancialsCompany financials have been released.Neutral
2020-06-16 17:46 ESTInsider TradeNeil Herskowitz has directly acquired 10,000 shares and currently holds 132,224 shares.Buy
2020-06-16 17:46 ESTInsider TradeJAY D KRANZLER has directly acquired 10,000 shares and currently holds 84,663 shares.Buy
2020-06-02 08:10 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on September 30, 2020.Sell
2020-06-02 08:10 ESTAnalyst RatingThe Analyst Target Price has increased from $12 to $12.5.Buy
2020-05-31 16:37 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 20:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-15 04:11 ESTFinancialsCompany financials have been released.Neutral
2020-05-13 00:35 ESTNewsAvenue Therapeutics EPS beats by $0.09N/A
2020-05-03 08:12 ESTFinancialsCompany financials have been released.Neutral
2020-04-17 07:15 ESTNewsAvenue Therapeutics Update: Shares A Steal Ahead Of Known PDUFA Action DateN/A
2020-04-11 02:12 ESTNewsAvenue Therapeutics EPS misses by $0.05N/A
2020-04-07 00:14 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 12:10 ESTEarnings EstimateAn EPS average of -$0.13 is estimated for the quarter ending on June 30, 2020.Buy

About Avenue Therapeutics, Inc (ATXI):

Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was founded in 2015 and is based in New York, New York. Effective as of December 31, 2019, Avenue Therapeutics, Inc. operates as a subsidiary of InvaGen Pharmaceuticals, Inc.

ATXI Quotes by TradingView

See Advanced Chart

General

  • Name Avenue Therapeutics, Inc
  • Symbol ATXI
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 4
  • Fiscal Year EndDecember
  • IPO Date2017-06-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.avenuetx.com
View More

Valuation

  • Forward PE 17.99
  • Price/Book (Most Recent Quarter) 35.53
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.33
  • Return on Assets -66%
  • Return on Equity -126%
  • Earnings Per Share -$1.96
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 102.16 million
  • Analyst Target Price $9
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 16.75 million
  • Shares Float 6.63 million
  • % Held by Insiders 6030%
  • % Held by Institutions 16.49%
  • Shares Short 356994
  • Shares Short Prior Month 383547
  • Short Ratio 3.01
  • Short % of Float 14%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.67
  • 52 Week High $12.34
  • 52 Week Low $2.85
  • 50 Day Moving Average 6.06
  • 200 Day Moving Average 6.28
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Avenue Therapeutics, Inc (ATXI) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Avenue Therapeutics, Inc (ATXI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-04$N/A-$0.06-$0.1040%
2020-06-302020-08-14$N/A-$0.11-$0.11-4.76%
2020-03-312020-05-11$N/A-$0.08-$0.1854.29%
2019-12-312020-03-30$N/A-$0.33-$0.29-15.79%
2019-09-302019-11-04$N/A-$0.14-$0.3256.25%
2019-06-302019-08-14$N/A-$0.43-$0.34-26.47%
2019-03-312019-05-13$N/A-$0.82-$0.43-90.7%
2018-12-312019-03-12$N/A-$0.37-$0.4720.72%
2018-09-302018-11-14$N/A-$0.25-$0.3935.35%
2018-06-302018-08-14$N/A-$0.45-$0.7237.21%
2018-03-312018-05-03$N/A-$1.03-$0.68-51.47%
2017-12-312018-03-01$N/A-$0.63
2017-09-302017-11-09$N/A-$0.30
2017-06-302017-08-11$N/A-$0.70

Avenue Therapeutics, Inc (ATXI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Avenue Therapeutics, Inc (ATXI) Chart:

Avenue Therapeutics, Inc (ATXI) News:

Below you will find a list of latest news for Avenue Therapeutics, Inc (ATXI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Avenue Therapeutics, Inc (ATXI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest ATXI Trades:

Date Shares Price
Jun 13, 2022 4:34 PM EST6$0.2567
Jun 13, 2022 4:42 PM EST3$0.258
Jun 13, 2022 7:06 PM EST100$0.2688
Jun 13, 2022 7:06 PM EST17$0.2688
Jun 13, 2022 7:14 PM EST4$0.2676

Avenue Therapeutics, Inc (ATXI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920073825/0001104659-20-073825-index.htm
2018-04-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1644963/000000000018011784/0000000000-18-011784-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465919059238/0001104659-19-059238-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000110465919063331/0001104659-19-063331-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465919071669/0001104659-19-071669-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920019770/0001104659-20-019770-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920020235/0001104659-20-020235-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920020237/0001104659-20-020237-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920024813/0001104659-20-024813-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920024815/0001104659-20-024815-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920027510/0001104659-20-027510-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/0001104659-20-031410-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920039972/0001104659-20-039972-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1644963/000110465920040345/0001104659-20-040345-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920050048/0001104659-20-050048-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920052889/0001104659-20-052889-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920059227/0001104659-20-059227-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000110465920059247/0001104659-20-059247-index.htm
2020-05-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1644963/000110465920067397/0001104659-20-067397-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920073725/0001104659-20-073725-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920073824/0001104659-20-073824-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920073825/0001104659-20-073825-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920095067/0001104659-20-095067-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000110465920095653/0001104659-20-095653-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000110465920097594/0001104659-20-097594-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000110465920114095/0001104659-20-114095-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000110465920121404/0001104659-20-121404-index.htm
2018-11-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1644963/000114036118043612/0001140361-18-043612-index.htm
2019-02-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1644963/000114036119002867/0001140361-19-002867-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114036119003329/0001140361-19-003329-index.htm
2019-02-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114036119003332/0001140361-19-003332-index.htm
2019-12-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114036119023473/0001140361-19-023473-index.htm
2017-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420417052957/0001144204-17-052957-index.htm
2017-10-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1644963/000114420417053129/0001144204-17-053129-index.htm
2017-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420417057438/0001144204-17-057438-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000114420417057449/0001144204-17-057449-index.htm
2018-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418000203/0001144204-18-000203-index.htm
2018-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418012034/0001144204-18-012034-index.htm
2018-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1644963/000114420418012321/0001144204-18-012321-index.htm
2018-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418017391/0001144204-18-017391-index.htm
2018-04-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1644963/000114420418020503/0001144204-18-020503-index.htm
2018-04-20PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418021620/0001144204-18-021620-index.htm
2018-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418022402/0001144204-18-022402-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418023427/0001144204-18-023427-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1644963/000114420418023428/0001144204-18-023428-index.htm
2018-05-02S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1644963/000114420418024773/0001144204-18-024773-index.htm
2018-05-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1644963/000114420418024781/0001144204-18-024781-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418024928/0001144204-18-024928-index.htm
2018-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000114420418024942/0001144204-18-024942-index.htm
2018-05-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1644963/000114420418025131/0001144204-18-025131-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418029953/0001144204-18-029953-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418030885/0001144204-18-030885-index.htm
2018-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418033791/0001144204-18-033791-index.htm
2018-06-124/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418033938/0001144204-18-033938-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418034228/0001144204-18-034228-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418034375/0001144204-18-034375-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418036289/0001144204-18-036289-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042948/0001144204-18-042948-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042950/0001144204-18-042950-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042952/0001144204-18-042952-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042954/0001144204-18-042954-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042956/0001144204-18-042956-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042958/0001144204-18-042958-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042960/0001144204-18-042960-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042962/0001144204-18-042962-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418042965/0001144204-18-042965-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418044259/0001144204-18-044259-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000114420418044262/0001144204-18-044262-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418059722/0001144204-18-059722-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420418059979/0001144204-18-059979-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000114420418060006/0001144204-18-060006-index.htm
2018-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420418064217/0001144204-18-064217-index.htm
2018-12-21DEFM14ADefinitive proxy statement relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1644963/000114420418065906/0001144204-18-065906-index.htm
2019-01-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1644963/000114420419002849/0001144204-19-002849-index.htm
2019-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419003774/0001144204-19-003774-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419004355/0001144204-19-004355-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419005339/0001144204-19-005339-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419005982/0001144204-19-005982-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419009857/0001144204-19-009857-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419013412/0001144204-19-013412-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1644963/000114420419013543/0001144204-19-013543-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419017010/0001144204-19-017010-index.htm
2019-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419019296/0001144204-19-019296-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419019691/0001144204-19-019691-index.htm
2019-04-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1644963/000114420419020407/0001144204-19-020407-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419022320/0001144204-19-022320-index.htm
2019-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419022325/0001144204-19-022325-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419022333/0001144204-19-022333-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419025468/0001144204-19-025468-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000114420419025546/0001144204-19-025546-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419029339/0001144204-19-029339-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419029899/0001144204-19-029899-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419029900/0001144204-19-029900-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419031487/0001144204-19-031487-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419031499/0001144204-19-031499-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419037052/0001144204-19-037052-index.htm
2019-08-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419037205/0001144204-19-037205-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419039191/0001144204-19-039191-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1644963/000114420419039748/0001144204-19-039748-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1644963/000114420419039777/0001144204-19-039777-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419042093/0001144204-19-042093-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419042094/0001144204-19-042094-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1644963/000114420419044714/0001144204-19-044714-index.htm
2019-01-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1644963/000149315219000824/0001493152-19-000824-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1644963/000149315220002533/0001493152-20-002533-index.htm
2018-12-11PREM14APreliminary proxy statements relating to merger or acquisitionhttps://www.sec.gov/Archives/edgar/data/1644963/000157104918000574/0001571049-18-000574-index.htm
2018-05-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1644963/999999999518001142/9999999995-18-001142-index.htm

Avenue Therapeutics, Inc (ATXI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avenue Therapeutics, Inc (ATXI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 6030%
Institutional Ownership: 1649%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-27Neil HerskowitzDirectorBuy10,000.00109,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419042093/0001144204-19-042093-index.htm
2020-02-25Neil HerskowitzDirectorBuy10,000.009.3193,100.00119,663.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920024813/0001104659-20-024813-index.htm
2020-02-26Neil HerskowitzDirectorBuy161.008.731,405.53119,824.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920027510/0001104659-20-027510-index.htm
2020-02-27Neil HerskowitzDirectorBuy2,400.008.2019,680.00122,224.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920027510/0001104659-20-027510-index.htm
2020-06-16Neil HerskowitzDirectorBuy10,000.00132,224.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920073824/0001104659-20-073824-index.htm
2019-09-12Elizabeth Garrett IngramDirectorBuy16,000.006.27100,320.0016,000.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419044714/0001144204-19-044714-index.htm
2018-06-08LINDSAY A MD ROSENWALDDirectorBuy5,234.004.3422,715.5625,234.00https://www.sec.gov/Archives/edgar/data/1644963/000114420418033791/0001144204-18-033791-index.htm
2018-06-28Joseph Walter VazzanoVP Finance & Corp. ControllerBuy1,351.003.664,944.6631,351.00https://www.sec.gov/Archives/edgar/data/1644963/000114420418036289/0001144204-18-036289-index.htm
2017-10-17Neil HerskowitzDirectorBuy1,000.005.015,010.0051,500.00https://www.sec.gov/Archives/edgar/data/1644963/000114420417052957/0001144204-17-052957-index.htm
2018-04-25Neil HerskowitzDirectorBuy1,000.003.803,800.0052,500.00https://www.sec.gov/Archives/edgar/data/1644963/000114420418022402/0001144204-18-022402-index.htm
2018-06-14Lucy LuPresident, CEOBuy5,000.004.0020,000.00557,333.00https://www.sec.gov/Archives/edgar/data/1644963/000114420418034375/0001144204-18-034375-index.htm
2019-08-09Joseph Walter VazzanoChief Financial OfficerSell2,375.005.5613,205.0056,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419039191/0001144204-19-039191-index.htm
2020-08-20Joseph Walter VazzanoChief Financial OfficerSell3,840.0012.1346,579.2057,412.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920097594/0001104659-20-097594-index.htm
2020-02-25Joseph Walter VazzanoChief Financial OfficerBuy1,200.009.0910,908.0057,863.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920024815/0001104659-20-024815-index.htm
2019-08-08Joseph Walter VazzanoChief Financial OfficerSell2,313.005.6212,999.0659,038.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419039191/0001144204-19-039191-index.htm
2020-03-09Joseph Walter VazzanoChief Financial OfficerBuy1,400.007.9911,186.0059,263.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/0001104659-20-031410-index.htm
2020-03-09Joseph Walter VazzanoChief Financial OfficerBuy100.007.97797.0059,363.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/0001104659-20-031410-index.htm
2020-03-10Joseph Walter VazzanoChief Financial OfficerBuy1,889.007.9414,998.6661,252.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920031410/0001104659-20-031410-index.htm
2019-01-28Neil HerskowitzDirectorBuy1,447.005.848,450.4868,610.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419003774/0001144204-19-003774-index.htm
2019-08-27JAY D KRANZLERDirectorBuy10,000.0074,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419042094/0001144204-19-042094-index.htm
2018-12-03Jeffrey PaleyDirectorBuy10,000.005.4854,754.0074,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420418064217/0001144204-18-064217-index.htm
2019-01-29Neil HerskowitzDirectorBuy8,553.005.9150,548.2377,163.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419003774/0001144204-19-003774-index.htm
2019-01-30Neil HerskowitzDirectorBuy650.005.913,841.5077,813.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419004355/0001144204-19-004355-index.htm
2018-12-10Jeffrey PaleyDirectorBuy5,000.004.7623,800.0079,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420418064217/0001144204-18-064217-index.htm
2020-06-16JAY D KRANZLERDirectorBuy10,000.0084,663.00https://www.sec.gov/Archives/edgar/data/1644963/000110465920073825/0001104659-20-073825-index.htm
2019-02-04Neil HerskowitzDirectorBuy7,000.005.9141,370.0084,813.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419005339/0001144204-19-005339-index.htm
2019-02-05Neil HerskowitzDirectorBuy1,850.005.7710,674.5086,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419005339/0001144204-19-005339-index.htm
2019-02-25Neil HerskowitzDirectorBuy5,000.005.4627,300.0091,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419009857/0001144204-19-009857-index.htm
2019-03-28Neil HerskowitzDirectorBuy600.005.113,066.0092,263.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419017010/0001144204-19-017010-index.htm
2019-03-29Neil HerskowitzDirectorBuy1,400.005.117,154.0093,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419017010/0001144204-19-017010-index.htm
2019-04-15Neil HerskowitzDirectorBuy1,000.004.524,520.0094,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419019691/0001144204-19-019691-index.htm
2019-06-17Neil HerskowitzDirectorBuy3,000.005.8817,640.0097,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419031499/0001144204-19-031499-index.htm
2019-06-18Neil HerskowitzDirectorBuy2,000.005.8311,660.0099,663.00https://www.sec.gov/Archives/edgar/data/1644963/000114420419031499/0001144204-19-031499-index.htm